Cytokine-Neuroantigen Fusion Proteins as a New Class of Tolerogenic, Therapeutic Vaccines for Treatment of Inflammatory Demyelinating Disease in Rodent Models of Multiple Sclerosis

por Mannie, Mark D., Blanchfield, J. Lori, Islam, S. M. Touhidul, Abbott, Derek J.
Publicado 2012

Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of expe...

por Abbott, Derek J, Blanchfield, J Lori, Martinson, David A, Russell, Sean C, Taslim, Najla, Curtis, Alan D, Mannie, Mark D
Publicado 2011